Dr. Adil Agarwal
#381Whole-time Director and CEO
41
Age
17y
Exp
15y
Tenure
7/10
Risk
🎓 Bachelor of Medicine and Surgery · Sri Ramachandra Medical College and Research Institute Chennai
📜 Master in Surgery - Ophthalmology, MBA · Sri Ramachandra University, Stanford University California
🏛️ None
CompensationTBP
Personality
7
Open
6
Cons
6
Extr
5
Agre
4
Neur
Dr Agarwal's Hea
Healthcare · Mid Cap
High Growth · Founder-Centric
About
Dr. Adil Agarwal is the Whole-time Director and CEO of Dr Agarwal's Hea, a Mid Cap company in the Healthcare sector with a market cap of ₹14K Cr. A Visionary leader with 17 years of experience, he is known for intuition-driven decision-making and aggressive acquirer strategy. Aggressive scaling of the eye-care network across India demonstrates a high-growth appetite and willingness to adopt modern clinical business models.
FAQ
What is Dr. Adil Agarwal's leadership style?
Dr. Adil Agarwal is classified as a Visionary leader. He is intuition-driven in decision-making, with a empire expander motivation and startup-speed pace of execution.
What is Dr. Adil Agarwal's educational background?
Dr. Adil Agarwal holds a Bachelor of Medicine and Surgery from Sri Ramachandra Medical College and Research Institute Chennai and a Master in Surgery - Ophthalmology, MBA from Sri Ramachandra University, Stanford University California.
Who is the CEO of Dr Agarwal's Hea?
Dr. Adil Agarwal is the Whole-time Director and CEO of Dr Agarwal's Hea. He has been with the company for 15 years and in the current role for 5 years.
Leadership DNA
ArchetypeVisionary
MotivationEmpire Expander
CrisisRevenue Hunter
DecisionIntuition-Driven
GrowthAggressive Acquirer
PeopleRelationship Led
InnovationFast-Follower
PaceStartup-Speed
PurposeMission-First
CustomerMass-Consumer
EmployerLearning Ground
BrandTrusted
FocusMarket Expansion
OrientationDeep Specialist
Leadership Evidence
“Aggressive scaling of the eye-care network across India demonstrates a high-growth appetite and willingness to adopt modern clinical business models.”
⚡ Crisis●●●○○
Dr. Agarwal's has consistently pursued aggressive geographic expansion and hospital openings even during challenging economic cycles to capture market share.
🎯 Motivation●●●●○
Under his leadership, the group has rapidly scaled from a regional player to a pan-India chain through aggressive footprint expansion and strategic consolidation.
👥 People●●●○○
As a family-led enterprise, the culture emphasizes deep-rooted loyalty and the continuity of the Agarwal family's vision across the organization.
📈 Growth●●●●○
The company has fueled its massive growth through strategic acquisitions of smaller eye care chains and hospitals across India.
💡 Innovation●●●○○
The company scales a standardized, high-quality clinical eye-care model across geographies rather than inventing new medical technologies.
🏃 Pace●●●●○
The company has pursued an aggressive inorganic growth strategy, rapidly acquiring and integrating regional eye-care chains across India.
🌱 Purpose●●●●○
The brand is built on the core mission of eliminating preventable blindness through accessible, high-volume eye care services.
🏷️ Brand●●●●○
The brand leverages the legacy of the Agarwal name to build deep consumer trust in a sensitive, high-stakes medical field.
🤝 Customer●●●●●
They operate a high-volume retail model targeting the general population with accessible and affordable eye-care services.
💼 Employer●●●○○
The institution is known for its structured clinical training programs that attract and develop young ophthalmologists.
📋 Mandate
Aggressive scaling of the eye-care hospital network necessitates a visionary leader to capitalize on consolidation opportunities in a fragmented healthcare market.
🏢 Culture●●●○○
High promoter holding of 75.5% with the founding family deeply involved in operational leadership and brand identity.
Financials
Revenue FY25₹2K Cr
PAT FY25₹83 Cr
Rev CAGR 5Y34.8%
OPM14.6%
NPM4.9%
ROE4.5%
ROCE7.8%
P/E107.6
Fwd P/E75.5
P/B7
D/E48.7
Promoter75.5%
Institutional16.6%
Mkt Cap₹14K Cr
Compensation
To Be Published
Data being verified from audited reports
